Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
Cardinal Health (CAH) Stock Price & Analysis
2,024 Followers
CAH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$79.25 - $115.52
Previous Close$99.72
Volume2.28M
Average Volume (3M)2.28M
Market Cap
$24.29B
Enterprise Value$24.42B
Total Cash (Recent Filing)$4.59B
Total Debt (Recent Filing)$4.72B
Price to Earnings (P/E)43.7
Beta0.56
Next Earnings
Aug 08, 2024EPS Estimate
$1.74Next Dividend Ex-Date
Jul 01, 2024Dividend Yield2.03%
Share Statistics
EPS (TTM)2.26
Shares Outstanding243,566,952
10 Day Avg. Volume2,339,224
30 Day Avg. Volume2,279,413
Standard Deviation0.08
R-Squared0.22
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-2.72
Price to Sales (P/S)0.12
Price to Cash Flow (P/CF)5.10
P/FCF Ratio5.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.11
Enterprise Value/Gross Profit0.12
Enterprise Value/Ebitda71.20
Forecast
1Y Price Target
$113.00Price Target Upside15.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Cardinal Health News
PremiumCompany Announcements
Cardinal Health Executives Discuss Quarterly Results and Future Projections
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company provided preliminary FY25 outlook, with EPS of >$7.50, despite the loss of renewal with OptumRx.
Stock ValuationCardinal Health shares are undervalued at 12.9x CY25 P/E and 8.7x EV/EBITDA on updated estimates, which is lower compared to industry peers.
Strategic InitiativesCardinal Health plans to offset the revenue loss from the Optum contract with new customer wins, specialty growth, and other actions.
Bears Say
Competitive PositionNon-renewal of OptumRx Pharmaceutical Distribution Contract could increase competitive intensity risks for the company.
Earnings ImpactLoss of the OptumRx contract is expected to impact EPS starting from the following fiscal year.
Financial PerformanceThe company faces a significant revenue cliff event with the loss of the UNH-Optum business, which may impact financials.
---
Ownership Overview
3.92% Insiders
23.96% Mutual Funds
32.86% Other Institutional Investors
39.26% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $79.25 and its highest was $115.52 in the past 12 months.
What is Cardinal Health’s market cap?
Currently, no data Available
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Aug 08, 2024 which is in 91 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on May 02, 2024. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $1.953 by $0.127.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.51 which represents an annual dividend yield of 2.03%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is $1.74.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 243,566,960 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $2.08 in its last earnings report, beating expectations of $1.953. Following the earnings report the stock price went up 0.793%.
Which hedge fund is a major shareholder of Cardinal Health?
Among the largest hedge funds holding Cardinal Health’s share is Elliott Investment Management LP. It holds Cardinal Health’s shares valued at 202M.
---
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$113.00 (15.97% Upside)
$113.00 (15.97% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 89%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 665.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.4%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.77%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
---
CAH Company Deck
---
CAH Earnings Call
Q3 2024
0:00 / 0:00
---
CAH Revenue Breakdown
92.68% Pharmaceutical
7.32% Medical
---
CAH Stock 12 Month Forecast
Average Price Target
$113.00
▲(15.97% Upside)
Best Analysts Covering CAH
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+18.28%
reiterated a buy rating 3 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +18.28% per trade.
---